You can buy or sell PTLA and other stocks, options, ETFs, and crypto commission-free!
Portola Pharmaceuticals, Inc. engages in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. Read More The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA.
South San Francisco, California
52 Week High
52 Week Low
— per share
Expected Aug 5, Pre-Market